Schedule 13G ownership disclosure
Audentes Therapeutics, Inc.
Security class unavailable · CUSIP: 05070R104
Event date: 2017-04-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.3800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193805-17-000693
- Form type
- SC 13G
- Filer
- Audentes Therapeutics, Inc.
- CIK
- CIK 1628738
- Filed
- Apr 26, 2017
- Reporting period
- Apr 24, 2017
- Description
- Schedule 13G beneficial ownership